These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2260863)

  • 1. Neuropathological substrate of dementia in Parkinson's disease.
    Jellinger K
    Ann Neurol; 1990 Nov; 28(5):723-4. PubMed ID: 2260863
    [No Abstract]   [Full Text] [Related]  

  • 2. The neuropathologic substrate of Parkinson disease dementia.
    Jellinger KA
    Acta Neuropathol; 2010 Jan; 119(1):151-3. PubMed ID: 19924423
    [No Abstract]   [Full Text] [Related]  

  • 3. Dementia in Parkinson's disease and (pre) senile dementia of Alzheimer type: morphological aspects and changes in the intracerebral MAO activity.
    Jellinger K; Riederer P
    Adv Neurol; 1984; 40():199-210. PubMed ID: 6695595
    [No Abstract]   [Full Text] [Related]  

  • 4. [Parkinson's disease and Alzheimer's disease--similarities in magnetic resonance imaging parameters and their possible explanation].
    Ebmeier KP; Besson JA; Cherryman G; Smith F
    Z Gerontol; 1988; 21(3):142-5. PubMed ID: 3407284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A modern hypothesis: The distinct pathologies of dementia associated with Parkinson's disease versus Alzheimer's disease.
    Farlow MR; Cummings J
    Dement Geriatr Cogn Disord; 2008; 25(4):301-8. PubMed ID: 18311077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological substrate of dementia in Parkinson's disease--its relation to DLB and DLBD.
    Jellinger KA
    Parkinsonism Relat Disord; 2006 Mar; 12(2):119-20. PubMed ID: 16337163
    [No Abstract]   [Full Text] [Related]  

  • 7. Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia.
    Chan-Palay V
    J Comp Neurol; 1988 Jul; 273(4):543-57. PubMed ID: 2463283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.
    Burton EJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT
    Brain; 2004 Apr; 127(Pt 4):791-800. PubMed ID: 14749292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathological distinction between Parkinson's dementia and Parkinson's plus Alzheimer's disease.
    de la Monte SM; Wells SE; Hedley-Whyte T; Growdon JH
    Ann Neurol; 1989 Sep; 26(3):309-20. PubMed ID: 2802531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can Alzheimer's type pathology influence the clinical phenotype of Parkinson's disease?
    Papapetropoulos S; Lieberman A; Gonzalez J; Mash DC
    Acta Neurol Scand; 2005 Jun; 111(6):353-9. PubMed ID: 15876335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An autopsy case of senile dementia with pathological features of Parkinson's disease].
    Oshima K; Tsuchiya K; Iritani S; Niizato K; Akiyama H; Ikeda K; Arai H
    No To Shinkei; 2004 Jul; 56(7):603-6. PubMed ID: 15379289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Regional cerebral blood flow in the aging human brain and in Alzheimer's dementia and Parkinson's disease].
    Melamed E
    Harefuah; 1982 Nov; 103(10):234-6. PubMed ID: 7182319
    [No Abstract]   [Full Text] [Related]  

  • 13. Parkinson's disease and dementia with Lewy bodies.
    Scott L
    Elder Care; 1999 Jun; 11(4):37-9. PubMed ID: 10614276
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuropathological substrates of Alzheimer's disease and Parkinson's disease.
    Jellinger K
    J Neural Transm Suppl; 1987; 24():109-29. PubMed ID: 3316494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffuse Lewy body disease: a common yet misdiagnosed dementia in which neuroleptics may be contraindicated.
    Scarbrough TJ
    Tenn Med; 1998 Feb; 91(2):58-60. PubMed ID: 9478123
    [No Abstract]   [Full Text] [Related]  

  • 16. Saccadic eye movement changes in Parkinson's disease dementia and dementia with Lewy bodies.
    Mosimann UP; Müri RM; Burn DJ; Felblinger J; O'Brien JT; McKeith IG
    Brain; 2005 Jun; 128(Pt 6):1267-76. PubMed ID: 15774501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dementia in Parkinson's disease. Morphometric data.
    Duyckaerts C; Gaspar P; Costa C; Bonnet AM; Hauw JJ
    Adv Neurol; 1993; 60():447-55. PubMed ID: 8420169
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathological basis for dementia in elderly patients with idiopathic Parkinson's disease.
    Yoshimura M
    Eur Neurol; 1988; 28 Suppl 1():29-35. PubMed ID: 3378559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffuse Lewy body disease: an important differential diagnosis in dementia with extrapyramidal features.
    Lennox G; Lowe JS; Godwin-Austen RB; Landon M; Mayer RJ
    Prog Clin Biol Res; 1989; 317():121-30. PubMed ID: 2602409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal loss in the substantia nigra in patients with Alzheimer's disease and Parkinson's disease in relation to extrapyramidal symptoms and dementia.
    Rinne JO; Rummukainen J; Paljärvi L; Säkö E; Mölsä P; Rinne UK
    Prog Clin Biol Res; 1989; 317():325-32. PubMed ID: 2602422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.